Cargando…

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

BACKGROUND: We investigated the clinical characteristics and treatment outcomes of Korean patients receiving first-line afatinib for advanced epidermal growth factor receptor mutation-positive (EGFRm(+)) non-small cell lung cancer (NSCLC) in a real-world setting. METHODS: Electronic case reports wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sung Yong, Choi, Chang-Min, Chang, Yoon Soo, Lee, Kye Young, Kim, Seung Joon, Yang, Sei Hoon, Ryu, Jeong Seon, Lee, Jeong Eun, Lee, Shin Yup, Park, Ji Young, Kim, Young-Chul, Oh, In-Jae, Jung, Chi Young, Lee, Sang Hoon, Yoon, Seong Hoon, Choi, Juwhan, Jang, Tae Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743522/ https://www.ncbi.nlm.nih.gov/pubmed/35070746 http://dx.doi.org/10.21037/tlcr-21-501

Ejemplares similares

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea
por: Kim, Taeyun, et al.
Publicado: (2021)

Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
por: Kim, Jehun, et al.
Publicado: (2023)

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non–Small Cell Lung Cancer: Updated Analysis of the RESET Study
por: Kim, Taeyun, et al.
Publicado: (2023)

Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting
por: Nam, Yunha, et al.
Publicado: (2021)

Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study
por: Yoon, Hee-Young, et al.
Publicado: (2020)

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer
por: Lee, Su Yeon, et al.
Publicado: (2021)

Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22
por: Jung, Hyun Ae, et al.
Publicado: (2022)

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
por: Kim, Hye-Ryoun, et al.
Publicado: (2013)

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
por: Lee, Jang Ho, et al.
Publicado: (2023)

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
por: Song, Si-Yeon, et al.
Publicado: (2020)

Parotid abscess at a single institute in Korea
por: Kim, Young Yoon, et al.
Publicado: (2018)

A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III) who have not progressed following definitive, platinum‐based, chemoradiation therapy (PLATINUM trial)
por: Choi, Juwhan, et al.
Publicado: (2022)

Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea
por: Choi, Juwhan, et al.
Publicado: (2019)

Effect of changes in the hearing aid subsidy on the prevalence of hearing loss in South Korea
por: Yoon, Chul Young, et al.
Publicado: (2023)

Gefitinib in Selected Patients with Pre-Treated Non-Small-Cell Lung Cancer: Results from a Phase IV, Multicenter, Non-Randomized Study (SELINE)
por: Lee, Kwan-Ho, et al.
Publicado: (2012)

Treatment Duration and Cost of Work-related Low Back Pain in Korea
por: Kim, Hyeong Su, et al.
Publicado: (2005)

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis
por: Yoon, Byung Woo, et al.
Publicado: (2019)

Relationship between Particulate Matter (PM(10)) and Airway Inflammation Measured with Exhaled Nitric Oxide Test in Seoul, Korea
por: Choi, Juwhan, et al.
Publicado: (2020)

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A
por: Park, Cheol‐Kyu, et al.
Publicado: (2020)

Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation
por: Kim, Eun Young, et al.
Publicado: (2019)

Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer
por: Lee, Sang Hoon, et al.
Publicado: (2020)

Tinea Incognito in Korea and Its Risk Factors: Nine-Year Multicenter Survey
por: Kim, Won-Jeong, et al.
Publicado: (2013)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

A situational analysis of ear and hearing care in South Korea using WHO ear and Hearing Care Situation Analysis tool
por: Lee, Juhyeong, et al.
Publicado: (2023)

Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
por: Yoon, Jun Sik, et al.
Publicado: (2021)

Clinical Characteristics of Vivax Malaria Outside Northern Gyeonggi Province Korea
por: Lee, Jae Hoon, et al.
Publicado: (2014)

Respiratory virus of severe pneumonia in South Korea: Prevalence and clinical implications
por: Kim, Hyung-Jun, et al.
Publicado: (2018)

Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer
por: Yoon, Seong-Hoon, et al.
Publicado: (2015)

A nationwide study of the incidence rate of herb-induced liver injury in Korea
por: Cho, Jung-Hyo, et al.
Publicado: (2017)

Ocular Manifestations of Biopsy-Proven Pulmonary Sarcoidosis in Korea
por: Choi, Seung Yong, et al.
Publicado: (2018)

Impact of Toxocariasis in Patients with Unexplained Patchy Pulmonary Infiltrate in Korea
por: Yoon, Young-Soon, et al.
Publicado: (2009)

Transplant physicians' perceptions of cord blood transplantation in Korea: a questionnaire survey
por: Choi, Byeong Seon, et al.
Publicado: (2014)

Cancer Incidence Among Adults With HIV in a Population-Based Cohort in Korea
por: Park, Boyoung, et al.
Publicado: (2022)

Serum Magnesium Level Is Associated with Type 2 Diabetes in Women with a History of Gestational Diabetes Mellitus: The Korea National Diabetes Program Study
por: Yang, Sae Jeong, et al.
Publicado: (2014)

Prognostic Significance of Tumor Location in T2 Gallbladder Cancer: A Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) Database Analysis
por: Lee, Seung Eun, et al.
Publicado: (2020)

Diagnostic Evaluation and Preparation of the Reference Information for River Restoration in South Korea
por: Lim, Chi Hong, et al.
Publicado: (2021)

New Delhi Metallo-Beta-Lactamase-Producing Enterobacteriaceae in South Korea Between 2010 and 2015
por: Yoon, Eun-Jeong, et al.
Publicado: (2018)

Nasal Carriage of 200 Patients with Nasal Bone Fracture in Korea
por: Lee, Jun Wook, et al.
Publicado: (2013)

Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
por: Kim, Taehee, et al.
Publicado: (2019)

Healthcare data quality assessment for improving the quality of the Korea Biobank Network
por: Kim, Ki-Hoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_furm4pus872qsrgue5j8vdlkin